Congress Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,769
| Closed | -$317K | – | 402 |
|
|
2024
Q4 | $317K | Sell |
8,769
-225
| -3% | -$8.14K | ﹤0.01% | 359 |
|
|
2024
Q3 | $280K | Sell |
8,994
-87
| -1% | -$2.71K | ﹤0.01% | 348 |
|
|
2024
Q2 | $243K | Sell |
9,081
-1,023,060
| -99% | -$27.4M | ﹤0.01% | 359 |
|
|
2024
Q1 | $35.2M | Buy |
1,032,141
+111,333
| +12% | +$3.8M | 0.25% | 109 |
|
|
2023
Q4 | $26.6M | Buy |
920,808
+3,644
| +0.4% | +$105K | 0.21% | 116 |
|
|
2023
Q3 | $25.3M | Buy |
917,164
+147,105
| +19% | +$4.06M | 0.22% | 114 |
|
|
2023
Q2 | $23.1M | Buy |
770,059
+209,422
| +37% | +$6.3M | 0.2% | 114 |
|
|
2023
Q1 | $20.3M | Buy |
560,637
+53,846
| +11% | +$1.95M | 0.19% | 109 |
|
|
2022
Q4 | $18.1M | Sell |
506,791
-672
| -0.1% | -$24K | 0.18% | 100 |
|
|
2022
Q3 | $17.2M | Buy |
507,463
+25,921
| +5% | +$877K | 0.18% | 97 |
|
|
2022
Q2 | $13.9M | Buy |
481,542
+17,441
| +4% | +$504K | 0.13% | 117 |
|
|
2022
Q1 | $15M | Buy |
464,101
+67,996
| +17% | +$2.2M | 0.13% | 115 |
|
|
2021
Q4 | $11.6M | Buy |
396,105
+82,250
| +26% | +$2.4M | 0.09% | 153 |
|
|
2021
Q3 | $8.37M | Buy |
313,855
+19,074
| +6% | +$509K | 0.07% | 179 |
|
|
2021
Q2 | $9.08M | Buy |
+294,781
| New | +$9.08M | 0.08% | 162 |
|